Fungicin M4: a narrow spectrum peptide antibiotic from Bacillus licheniformis M-4

Area of Science:

• Microbiology
• Biochemistry
• Peptide Science

Background:

• Antimicrobial peptides (AMPs) are crucial components of innate immunity.
• The discovery of novel AMPs with unique properties is essential for combating antimicrobial resistance.

Purpose of the Study:

• To isolate and characterize a novel antifungal peptide produced by Bacillus licheniformis M-4.
• To determine the amino acid composition and inhibitory spectrum of the purified peptide.

Main Methods:

• Isolation and purification of the antifungal peptide from Bacillus licheniformis M-4 culture.
• Amino acid analysis of the purified peptide.
• Determination of the inhibitory spectrum against various fungal and bacterial strains.
• Assessment of biocidal activity on liquid cultures.

Main Results:

• A 3.4 kDa hydrophilic antifungal peptide, named fungicin M4, was identified.
• Fungicin M4 contains Glu (8), Arg (5), Pro (4), Tyr (8), Val (3), Met (2), and Orn (4).
• The peptide demonstrated inhibitory activity against Microsporum canis, Mucor mucedo, Mucor plumbeus, Sporothrix schenckii, Bacillus megaterium, and Corynebacterium glutamicum.
• Fungicin M4 exhibited biocidal activity against Sporothrix schenckii.

Conclusions:

• Fungicin M4 is a novel antifungal peptide with a defined amino acid composition.
• The peptide possesses a specific inhibitory spectrum and biocidal activity, particularly against Sporothrix schenckii.
• Fungicin M4 represents a potential candidate for antimicrobial therapeutic development.